Virology Journal (Jul 2021)

Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study

  • Rui Huang,
  • Li Zhu,
  • Leyang Xue,
  • Xuebing Yan,
  • Jian Wang,
  • Songping Huang,
  • Biao Zhang,
  • Tianmin Xu,
  • Fang Ji,
  • Chunyang Li,
  • Fang Ming,
  • Yun Zhao,
  • Yang Li,
  • Juan Cheng,
  • Yinling Wang,
  • Huaping Shao,
  • Shuqin Hong,
  • Kang Chen,
  • Xiang-an Zhao,
  • Dawen Sang,
  • Lei Zou,
  • Haiyan Zhao,
  • Xinying Guan,
  • Xiaobing Chen,
  • Biyun Xu,
  • Juan Xia,
  • Yuxin Chen,
  • Xiaomin Yan,
  • Jie Wei,
  • Jiacheng Liu,
  • Longgen Liu,
  • Chuanwu Zhu,
  • Chao Wu

DOI
https://doi.org/10.1186/s12985-021-01615-y
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Background The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. Methods A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collected. The associated factors of SARS-CoV-2 clearance were analyzed. Results The median duration of hospitalization was 16.0 days (interquartile range [IQR] 13.0–21.0 days). On multivariate Cox regression analysis, age > 60 years (hazard ratio [HR] 0.643, 95% confidence interval [CI] 0.454–0.911, P = 0.013) was associated with the delayed SARS-CoV-2 clearance, while the atomized inhalation of interferon α-2b could improve the clearance of SARS-CoV-2 (HR, 1.357, 95% CI 1.050–1.755, P = 0.020). Twenty-six (7.9%) patients developed respiratory failure and 4 (1.2%) patients developed ARDS. Twenty (6.1%) patients were admitted to the ICU, while no patient was deceased. Conclusions Our study found that age > 60 years was associated with the delayed SARS-CoV-2 clearance, while treated with atomized inhalation of interferon α-2b could promote the clearance of SARS-CoV-2.

Keywords